Sutro Biopharma (STRO) Free Cash Flow (2017 - 2026)
Sutro Biopharma (STRO) free cash flow from Sep 30, 2017 to Mar 31, 2026. The TTM Sutro Biopharma (STRO) free cash flow is -$152M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Sutro Biopharma (STRO) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -22.13% |
| 3 Years TTM | +89.75% |
| 5 Years TTM | +13.56% |
Annual Free Cash Flow change of Sutro Biopharma (STRO)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | -$42M | -76.16% |
| 2025 | -$177M | -7.47% |
| 2024 | -$192M | +71.60% |
| 2023 | -$112M | -3244.23% |
| 2022 | $3.55M | -104.35% |
| 2021 | -$82M | +20.47% |
| 2020 | -$68M | +4.28% |
| 2019 | -$65M | -684.71% |
| 2018 | $11M | -127.53% |
| 2017 | -$40M | +130.27% |
| 2016 | -$18M | N/A |
Comparison Sutro Biopharma (STRO) five years free cash flow CAGR with competitors
Sutro Biopharma (STRO) five years free cash flow CAGR is 14.00%.